Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiondeubiquitinase activator activity

DMWD WDR20

1.43e-057172GO:0035800
GeneOntologyMolecularFunctionpeptidase activator activity

DMWD NLRP1 WDR20

2.71e-0570173GO:0016504
GeneOntologyMolecularFunctionlong-chain fatty acid-CoA ligase activity

ACSBG1 ACSF2

7.12e-0515172GO:0004467
GeneOntologyMolecularFunctionfatty acid ligase activity

ACSBG1 ACSF2

2.19e-0426172GO:0015645
GeneOntologyMolecularFunctionCoA-ligase activity

ACSBG1 ACSF2

2.36e-0427172GO:0016405
GeneOntologyMolecularFunctionacid-thiol ligase activity

ACSBG1 ACSF2

3.13e-0431172GO:0016878
GeneOntologyMolecularFunctionpattern recognition receptor activity

NLRP1 NOD2

3.99e-0435172GO:0038187
GeneOntologyMolecularFunctionligase activity, forming carbon-sulfur bonds

ACSBG1 ACSF2

5.49e-0441172GO:0016877
GeneOntologyMolecularFunctionpeptidase regulator activity

DMWD NLRP1 WDR20

1.25e-03257173GO:0061134
GeneOntologyBiologicalProcessresponse to muramyl dipeptide

NLRP1 NOD2

1.03e-0421152GO:0032495
HumanPhenoAcute phase response

NLRP1 CLDN16 NOD2

2.42e-0420343HP:0033331
HumanPhenoKeratoconjunctivitis sicca

NLRP1 NOD2

4.94e-044742HP:0001097
HumanPhenoPolyarticular arthritis

NLRP1 NOD2

5.60e-045042HP:0005764
HumanPhenoKeratoconjunctivitis

NLRP1 NOD2

6.05e-045242HP:0001096
HumanPhenoPolyarticular arthropathy

NLRP1 NOD2

6.05e-045242HP:0005195
DomainNPIP

NPIPA7 NPIPA1 NPIPB2 NPIPA3 NPIPA5

2.14e-1214215IPR009443
DomainNACHT

NLRP1 NOD2

3.00e-0423212PS50837
DomainNACHT_NTPase

NLRP1 NOD2

3.00e-0423212IPR007111
DomainAMP-binding_CS

ACSBG1 ACSF2

3.85e-0426212IPR020845
DomainCARD

NLRP1 NOD2

4.47e-0428212PF00619
DomainAMP_BINDING

ACSBG1 ACSF2

4.47e-0428212PS00455
DomainAMP-binding

ACSBG1 ACSF2

5.14e-0430212PF00501
DomainAMP-dep_Synth/Lig

ACSBG1 ACSF2

5.14e-0430212IPR000873
DomainCARD

NLRP1 NOD2

5.49e-0431212IPR001315
DomainCARD

NLRP1 NOD2

6.23e-0433212PS50209
DomainPMP22/EMP/MP20/Claudin

TMEM178B CLDN16

1.16e-0345212IPR004031
DomainLRR_6

NLRP1 NOD2

1.72e-0355212PF13516
Domain-

NLRP1 NOD2

4.84e-03932121.10.533.10
DomainDEATH-like_dom

NLRP1 NOD2

5.47e-0399212IPR011029
DomainLRR

NLRP1 NOD2

2.12e-02201212PS51450
PathwayWP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY

NLRP1 NOD2

5.35e-0441122M39698
PathwayREACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS

NLRP1 NOD2

7.03e-0447122MM14664
PathwayREACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS

NLRP1 NOD2

9.97e-0456122M1074
PathwayKEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY

NLRP1 NOD2

1.22e-0362122M15569
Pubmed

Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.

NPIPA1 NPIPA3 NPIPA5

8.78e-10422318055785
Pubmed

Positive selection of a gene family during the emergence of humans and African apes.

NPIPA1 NPIPA8

3.82e-07222211586358
Pubmed

NLRs join TLRs as innate sensors of pathogens.

NLRP1 NOD2

2.29e-06422215967716
Pubmed

The dystrophia myotonica WD repeat-containing protein DMWD and WDR20 differentially regulate USP12 deubiquitinase.

DMWD WDR20

2.29e-06422233844468
Pubmed

Transcription Profiling of NOD-like Receptors in the Human Cornea with Disease.

NLRP1 NOD2

2.29e-06422226902715
Pubmed

CLAN, a novel human CED-4-like gene.

NLRP1 NOD2

3.82e-06522211472070
Pubmed

Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling.

NLRP1 NOD2

3.82e-06522218495787
Pubmed

Evaluation of Nod-like receptor (NLR) effector domain interactions.

NLRP1 NOD2

5.72e-06622219337385
Pubmed

A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.

NLRP1 NOD2

8.01e-06722218511561
Pubmed

Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis.

NLRP1 NOD2

8.01e-06722217620097
Pubmed

Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses.

NLRP1 NOD2

1.37e-05922215107016
Pubmed

Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46.

DMWD WDR20

1.37e-05922221183687
Pubmed

Novel Cul3 binding proteins function to remodel E3 ligase complexes.

DMWD NLRP1

2.94e-044022225011449
Pubmed

Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.

NLRP1 MCOLN3 WDR20

5.54e-0425722330945288
Pubmed

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

SLC35F4 NOD2

6.18e-045822217554300
InteractionCASP1 interactions

DMWD NLRP1 NOD2

4.89e-0586173int:CASP1
InteractionC10orf67 interactions

ACSF2 NOD2

6.06e-0514172int:C10orf67
InteractionNLRC4 interactions

NLRP1 NOD2

1.14e-0419172int:NLRC4
Cytoband16p13.11

NPIPA1 NPIPA3 NPIPA5

1.68e-072322316p13.11
CytobandEnsembl 112 genes in cytogenetic band chr16p13

NPIPA7 NPIPA1 NPIPB2 NPIPA3 NPIPA5

1.55e-06426225chr16p13
CytobandEnsembl 112 genes in cytogenetic band chr1p22

MTF2 MCOLN3

1.96e-03137222chr1p22
GeneFamilyNLR family

NLRP1 NOD2

1.65e-0425142666
GeneFamilyAcyl-CoA synthetase family

ACSBG1 ACSF2

1.79e-042614240
GeneFamilyWD repeat domain containing|Caspase recruitment domain containing|Apoptosome

NLRP1 NOD2

2.39e-0430142959
GeneFamilyWD repeat domain containing

DMWD WDR20

1.70e-02262142362
GeneFamilySolute carriers

SLC17A1 SLC35F4

3.64e-02395142752
ToppCellCOVID-19-kidney-Epithelial_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type

TMEM178B SLC17A1 NPIPB2

2.68e-051192237cde7c73bb71f5e1911706e51c2ea6dcc72930ac
ToppCellCOVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type

TMEM178B SLC17A1 ACSF2

1.03e-04187223738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM178B SLC17A1 ACSF2

1.06e-0418922313fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM178B SLC17A1 ACSF2

1.06e-04189223204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM178B SLC17A1 ACSF2

1.09e-041912233c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM178B SLC17A1 ACSF2

1.09e-041912231c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM178B SLC17A1 ACSF2

1.14e-041942237002937e8903e037332a215d00fbc7c7843b33f2
Drugthiomalate

PRKD3 NLRP1 NOD2

9.42e-0650193CID000006268
Drugalpha-acetoxy-N-nitrosopyrrolidine

NPIPA1 NLRP1

9.88e-066192CID000107766
DrugEtofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A

DMWD SYNJ1 ACSBG1 NOD2

1.76e-051931943989_UP
DrugNDPhA

NPIPA1 NOD2

8.91e-0517192CID000006838
Drugtiopronin

NLRP1 NOD2

1.96e-0425192CID000005483
Drugdihydrochloride

PRKD3 NLRP1 CLDN16

2.98e-04159193CID000070978
DrugMR-M

NLRP1 WDR20

3.43e-0433192CID000445262
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ACSBG1 NLRP1 ACSF2

3.57e-041691931000_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA

ACSBG1 NLRP1 ACSF2

3.63e-041701931014_UP
DrugAC1NSKHR

PRKD3 NLRP1

3.64e-0434192CID005311362
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.76e-041721932330_UP
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.76e-041721935217_UP
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.76e-041721935580_UP
Drugtetradotoxin

DMWD PRKD3 NLRP1 NOD2

3.81e-04428194CID000020382
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.82e-041731935625_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.82e-041731931672_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.82e-041731935308_UP
Drugtrichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA

ACSBG1 NLRP1 ACSF2

3.82e-04173193981_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.88e-041741935260_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.88e-041741937179_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.88e-041741935572_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.88e-041741935231_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.95e-041751934153_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.95e-041751933428_UP
DrugHC toxin from Helminthosporium carbonum; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

ACSBG1 NLRP1 ACSF2

3.95e-04175193909_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

3.95e-041751935417_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.02e-041761936972_UP
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771936980_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771934710_UP
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771931645_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771936784_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771933462_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771934954_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771935209_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771934770_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA

ACSBG1 NLRP1 ACSF2

4.08e-041771931072_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771936493_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771933312_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.08e-041771935945_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.15e-041781934388_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.15e-041781936454_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.22e-041791936951_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.22e-041791937005_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.22e-041791935336_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.22e-041791936993_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801937236_UP
DrugSAHA; Up 200; 10uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801936939_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801937407_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801935484_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801936579_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.29e-041801936064_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.36e-041811931471_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.36e-041811937453_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.36e-041811936276_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.36e-041811931535_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.43e-041821935511_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.43e-041821936932_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.43e-041821935017_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

SYNJ1 ACSBG1 NLRP1

4.65e-041851936916_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.65e-041851931637_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.72e-041861937499_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.72e-041861936891_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.80e-041871936709_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 ACSF2

4.80e-041871935976_UP
DrugLeflunomide [75706-12-6]; Up 200; 14.8uM; HL60; HT_HG-U133A

ACSBG1 NLRP1 NOD2

5.02e-041901932539_UP
Drugallodeoxycholic acid

DMWD PRKD3 NLRP1

5.02e-04190193CID000002987
DrugAlbendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A

DMWD SYNJ1 MTF2

5.18e-041921933164_DN
DrugDeltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A

DMWD ACSBG1 NOD2

5.26e-041931934306_UP
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A

DMWD SYNJ1 NOD2

5.34e-041941936833_UP
DrugOxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

DMWD MCOLN3 ACSF2

5.34e-041941933168_DN
DrugApomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A

DMWD MTF2 ABHD14A

5.42e-041951931505_DN
DrugBacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A

PRKD3 ABHD14A MCOLN3

5.50e-041961937448_DN
DrugSB 202190; Up 200; 1uM; MCF7; HT_HG-U133A

SYNJ1 ABHD14A MCOLN3

5.50e-041961937054_UP
DrugLobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A

PRKD3 SYNJ1 MCOLN3

5.58e-041971936258_UP
DrugNapelline [5008-52-6]; Up 200; 11.2uM; HL60; HT_HG-U133A

SYNJ1 NLRP1 NOD2

5.58e-041971932522_UP
DrugBenzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A

DMWD SYNJ1 ACSBG1

5.58e-041971931843_UP
DrugTodralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A

SYNJ1 MTF2 MCOLN3

5.58e-041971931677_UP
DrugZimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A

PRKD3 SYNJ1 ABHD14A

5.66e-041981931512_UP
DrugPrilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A

ACSBG1 NLRP1 CLDN16

5.66e-041981933624_UP
DrugOxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HT_HG-U133A

SYNJ1 NLRP1 MCOLN3

5.66e-041981934246_UP
DrugChlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

ACSBG1 MCOLN3 ACSF2

5.66e-041981933198_DN
DrugGibberellic acid [77-06-5]; Up 200; 11.6uM; HL60; HT_HG-U133A

DMWD NLRP1 NOD2

5.66e-041981932910_UP
DrugGabazine [105538-73-6]; Up 200; 10.8uM; PC3; HT_HG-U133A

SYNJ1 NLRP1 MCOLN3

5.66e-041981934236_UP
DrugRoxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

DMWD ABHD14A MCOLN3

5.66e-041981933511_DN
DrugErythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A

DMWD MTF2 MCOLN3

5.66e-041981931510_DN
DrugCTK2H7103

ACSBG1 MTF2 SLC17A1

6.63e-04209193CID005462309
DrugNPC 15437

PRKD3 NLRP1

6.68e-0446192CID000004548
Drugsodium selenite

NLRP1 NOD2

6.97e-0447192CID000024934
Drugphorbol 12,13-diacetate

PRKD3 NOD2

7.27e-0448192CID000072293
Drugdimercaprol

NLRP1 NOD2

7.27e-0448192CID000003080
Drugthiamylal

DMWD PRKD3

7.58e-0449192CID003032285
Drugpropinox

ACSBG1 NOD2

7.58e-0449192CID000017699
DiseaseAutoinflammatory disorder

NLRP1 NOD2

2.31e-0435192C3860213
Diseasepeptide measurement

ACSBG1 NLRP1

2.22e-03109192EFO_0010520

Protein segments in the cluster

PeptideGeneStartEntry
CWLGMAGSLGCFLAG

CLDN16

166

Q9Y5I7
LCIRGYCVMLGYWGE

ACSF2

461

Q96CM8
LMKSYFGGLLCVCWS

DMWD

321

Q09019
CGGPGDWYLKMLQCC

MTF2

206

Q9Y483
MFCCLGYEWLSGGCK

NPIPA1

1

Q9UND3
MVGALCGCWFRLGGA

ABHD14A

1

Q9BUJ0
MIYLGYCFCGWIVLG

MCOLN3

421

Q8TDD5
MAGGAWGRLACYLEF

NLRP1

1

Q9C000
TFCDYCGEMLWGLVR

PRKD3

166

O94806
MFCCLGYEWLSGGCK

NPIPA3

1

F8WFD2
GEICLWGRTIFMGYL

ACSBG1

516

Q96GR2
MFCCLGYEWLSGGCT

NPIPA7

1

E9PJI5
MFCCLGYEWLSGGCT

NPIPA8

1

P0DM63
LGCCWDRGLMQYVAG

TMEM178B

191

H3BS89
YGVNCDDWLLRLMCG

SYNJ1

171

O43426
MFCCLGYEWLSGGCK

NPIPA5

1

E9PKD4
LGWPMVFYIFGACGC

SLC17A1

196

Q14916
GTMKSYFGGLLCVCW

WDR20

256

Q8TBZ3
GCLCGMAGLWLAFNI

SLC35F4

401

A4IF30
GRLALWGLGMCCYVF

NOD2

551

Q9HC29
MFCCLGYEWLSGGCK

NPIPB2

1

A6NJ64
CRWTKSMLRGRGGCY

TYW1

381

Q9NV66